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ttp://dx.doi.org/10.1016/j.ajpath.2013.01.001Increased vascular impedance in the fetoplacental circulation is associated with fetal hypoxia and growth
restriction. We sought to investigate the role of hydrogen sulﬁde (H2S) in regulating vasomotor tone in the
fetoplacental vasculature. H2S is produced endogenously by catalytic activity of cystathionine b-synthase
and cystathionine g-lyase (CSE). Immunohistochemical analysis localized CSE to smooth muscle cells
encircling arteries in stem villi. Immunoreactivity was reduced in placentas from pregnancies with severe
early-onset growth-restriction and preeclampsia displaying abnormal umbilical artery Doppler waveforms
comparedwith preeclamptic placentas with normal waveforms and controls. These ﬁndingswere conﬁrmed
at the protein and mRNA levels. MicroRNA-21, which negatively regulates CSE expression, was increased in
placentas with abnormal Doppler waveforms. Exposure of villus explants to hypoxia-reoxygenation
signiﬁcantly reduced CSE protein and mRNA and increased microRNA-21 expression. No changes were
observed in cystathionine b-synthase expression, immunolocalized principally to the trophoblast, in
pathologic placentas or in vitro. Finally, perfusion of normal placentas with an H2S donor, after pre-
constriction with a thromboxane mimetic, resulted in dose-dependent vasorelaxation. Glibenclamide and
NG-nitro-L-arginine methyl ester partially blocked the effect, indicating that H2S acts through
ATP-sensitive Kþ channels and nitric oxide synthesis. These results demonstrate that H2S is a powerful
vasodilator of the placental vasculature and that expression of CSE is reduced in placentas associated
with increased vascular resistance. (Am J Pathol 2013, 182: 1448e1458; http://dx.doi.org/10.1016/
j.ajpath.2013.01.001)Supported by the Wellcome Trust (084804/2/08/Z). E.A.H. was partially
funded by the U-Apoya Program, Universidad de Chile.
T.C-D. and E.A.H. contributed equally to this work.One of the principal functions of the placenta is to act as a gas
exchanger, which it achieves by bringing the maternal and
fetal circulations into close approximation over a large surface
area. The ﬂow in these circulations is now routinely assessed
noninvasively in vivo in high-risk pregnancies using Doppler
ultrasound.1 Umbilical artery Doppler velocimetry provides
an indirect measure of downstream vascular resistance in
the fetoplacental vasculature.2 Pregnancies complicated by
severe early-onset forms of preeclampsia (PE)3 and/or intra-
uterine growth restriction (IUGR)4 typically exhibit increased
resistance in the umbilical circulation, with absent or even
reversed end-diastolic ﬂow velocity. These highly abnormalstigative Pathology.
.Doppler ﬂow patterns are associated with a poor perinatal
prognosis,5 in part because they identify a subset of preg-
nancies with chronic fetal hypoxia, metabolic acidosis, and
reduced circulating glucose and amino acid levels.6e8
In the human placenta, the umbilical arteries branch into
a series of resistance arteries contained in the distributing stem
villi. These arteries eventually supply the capillary network in
the terminal villi that are the principal sites of gaseous
Hydrogen Sulﬁde and Human Placentaexchange. In the absence of nerves in the placenta, vasomotor
control of the resistance arteries is performed by locally
produced vasoreactive molecules. To date, nitric oxide (NO)9
and carbonmonoxide (CO)10 have been shown to have dilator
actions in vitro. Accumulating studies suggest that hydrogen
sulﬁde (H2S) also exerts signiﬁcant effects in the adult
cardiovascular system, mainly via endothelium-independent
vasodilation.11 However, its potential role in the placental
circulation has not been investigated. We, therefore, investi-
gated expression of the enzymes generatingH2S in pathologic
placentas with and without increased vascular resistance.
Endogenous H2S production is catalyzed by cystathionine
b-synthase (CBS) and cystathionineg-lyase (CSE).12,13 CSE is
the dominant enzyme for synthesis ofH2S in the cardiovascular
system, and reduced expression/activity and decreased H2S
expression contribute to the pathogenesis of pulmonary
hypertension in rodents.14 Although CBS is not present
in vascular tissues, CBS deﬁciency leads to secondary
hypertension and endothelial dysfunction through hyper-
homocysteinemia.15,16 The most compelling evidence for the
role of H2S in the cardiovascular system comes from studies
using CSE single and double knockout mice, where signiﬁ-
cantly higher systolic arterial blood pressure was reported in
CSE/ and, to a lesser extent,CSEþ/- comparedwithCSEþ/þ
mice. In addition, CSE/ mice are highly sensitive to H2S-
mediated vasodilatation compared with wild-type mice.17 The
mechanism of action of H2S has been best described in the
nervous system, where ATP-sensitive Kþ (KATP) channels
18
and N-methyl-D-aspartate receptors19 have been identiﬁed as
the prime targets. Similarly, KATP channels present in vascular
smooth muscle cells (SMCs) were identiﬁed as the target
protein of H2S, mediating its vascular effect.
20 In addition, the
vascular effect ofH2S can be potentiated byNO.
20,21 In viewof
these ﬁndings, we tested the effect of the KATP channel blocker
glibenclamide and the NO synthesis blocker NG-nitro-L-
arginine methyl ester (L-NAME) when applied with sodium
hydrosulﬁde (NaHS) in perfused human placentas.
In intrauterine tissues, Patel et al22 conﬁrmed endogenous
H2S placental production and release and the presence of
placental CSE and CBS in rats and humans. Holwerda
et al23 showed decreased placental mRNA expression of
CBS in early-onset PE, and You et al24 showed down-
regulation of CBS and CSE mRNA and of CBS protein
expression in the myometrium during labor. However, the
vasoactive effects of H2S in the fetoplacental vascular bed
remain unexplored in any species.
We hypothesized that placentas from pregnancies
complicated by the severe forms of PE and IUGR with
abnormal umbilical artery Doppler waveforms show impaired
endogenous H2S production secondary to a reduction in the
H2S-producing enzymes. To test this hypothesis, the ﬁrst aim
was to determine the expression of CSE and CBS in
cesarean-delivered human placentas from healthy pregnan-
cies and from pregnancies complicated by IUGR or PE. To
test the relationship between local H2S production and
umbilical artery Doppler waveforms in high-risk pregnancies,The American Journal of Pathology - ajp.amjpathol.orgwe additionally split the PE placentas into two groups with
respect to umbilical artery Doppler ﬁndings, ie, PE with
abnormal umbilical artery Doppler ﬁndings (PE-AD) and PE
with normal umbilical artery Doppler ﬁndings and, thus,
normal resistance (PE-ND). Because CSE protein and mRNA
expression were signiﬁcantly reduced in IUGR and PE-AD
samples, we further explored its regulation by examining
the expression of microRNA-21 (miR-21). Recent evidence
suggests that miR-21 overexpression participates in CSE/
H2S-mediated SMC differentiation by repressing the protein
expression of CSE and SP1, inhibiting H2S production,
stimulating SMC proliferation, and reducing SMC differen-
tiation.25 Second, because oxidative stress due to placental
ischemia-reperfusion injury is a major component of the
placental pathology associated with PE and IUGR,26,27 we
examined the effects of hypoxia-reoxygenation (H/R) on the
gene and protein expression of CSE and CBS and that of
miR-21 in human placental explants in vitro. The ﬁnal aim
was to test whether H2S plays a role in dilating the human
placenta by perfusing preconstricted healthy human cesarean-
delivered placentas with an H2S donor. The mechanism of
action of H2S in the fetoplacental circulation was determined
using the KATP channel blocker glibenclamide and the NO
synthesis blocker L-NAME.
Materials and Methods
Placental Collection and Ethical Approval
IUGR was diagnosed ultrasonically when abdominal
circumference measurements were below the 10th percen-
tile28 and was conﬁrmed at birth by a neonatal weight below
the 10th percentile.29 Of the six IUGR cases, three had
normal umbilical artery Doppler velocimetry ﬁndings, two
had abnormal umbilical arterial Doppler velocimetry ﬁnd-
ings, and one had absent end diastolic blood ﬂow of the
umbilical artery (Table 1). PE was deﬁned as the onset of
gestational hypertension and proteinuria after 20 weeks of
gestation, and the cases examined herein were early-onset
PE. We additionally divided the PE category into two
groups based on the results of Doppler velocimetry, ie,
PE-AD (n Z 7) and PE-ND (n Z 7). Hypertension was
deﬁned as two or more recordings of a diastolic blood
pressure of 90 mm Hg taken 4 hours apart (PE-AD:
means  SEM systolic blood pressure, 171  14 mm Hg,
and means SEM diastolic blood pressure, 109 7 mm Hg;
PE-ND: means  SEM systolic blood pressure, 172 
15 mm Hg, and means  SEM diastolic blood pressure,
102  4 mm Hg). Proteinuria was deﬁned as the excretion
of 300 mg of protein over 24 hours. The PE-AD group
included all the criteria for IUGR, and birth weight was
signiﬁcantly higher in the PE-ND group (10th to 50th
percentile) (Table 1).
Human placentas for perfusion and explant culture were
collected with Cambridge Local Ethical Committee approval
and informed written patient consent on an anonymous basis.1449
Table 1 Clinical Information for Term Healthy and Pathologic Placentas
Characteristic
Group
Healthy IUGR PE-AD PE-ND
Gestational age (weeks) 39  0.6 32  3.5* 28.5  1.3* 29.5  1.5*
Fetal weight (g) 3615  417 1045  465* 928  159* 1255  226*
Umbilical artery Doppler H Z 6 NH Z 3
PEDF Z 2
AREDF Z 1
PEDF Z 2
AREDF Z 5
H Z 7
Data are presented as means  SD.
*P < 0.001.
AREDF, absent or reversed end-diastolic blood ﬂow; H, healthy; PEDF, abnormal but present end-diastolic blood ﬂow.
Cindrova-Davies et alGestational age was calculated from the last menstrual period
and was conﬁrmed by routine ultrasonography at 11 to 12
weeks of gestation. All the placentas were delivered at term
by elective cesarean birth from nonlaboring normotensive
healthy singleton pregnancies, with no history of cigarette
smoking, diabetes, autoimmune diseases, or thrombophilic
conditions.
Culture of Placental Explants
Placental tissue was collected from cesarean-delivered sin-
gleton pregnancies within 10 minutes of delivery. Villous
samples were taken midway between the chorionic and basal
plates from the periphery of three lobules free of visible
infarction, calciﬁcation, hematoma, or tears on a random
systematic basis. Samples were brieﬂy rinsed in cold PBS
and placed in ice-cold transport medium (TCS large-vessel
endothelial cell basal medium; TCS Cellworks, Milton
Keynes, UK) containing 2% fetal bovine serum, heparin,
hydrocortisone, human epidermal growth factor, human
basic ﬁbroblast growth factor, 25 mg/mL of gentamicin and
50 ng/mL of amphotericin B, 1 mmol/L vitamin C, and
1 mmol/L Trolox that had been equilibrated with 5%O2/90%
N2/5% CO2.
After transport to the laboratory on ice for approximately
1 hour, placental samples were further dissected into small
pieces approximately 5 mm in diameter in ice-cold culture
medium in a glove box under 10% O2/85% N2/5% CO2, as
previously described.30 Brieﬂy, 5-mm3 placental explants
were cultured on individual Costar Netwell inserts (Corning
Inc., Lowell, MA) (24-mm diameter, 500-mm mesh) in 4 mL
of the large-vessel endothelial cell basal medium containing
2% fetal bovine serum, heparin, hydrocortisone, human
epidermal growth factor, human basic ﬁbroblast growth
factor, 25 mg/mL of gentamicin, and 50 ng/mL of ampho-
tericin B, equilibrated with 5% O2/90% N2/5% CO2 per well
in 6-well plates for 24 hours. Approximately 6 to 10 pieces
were added to each well, depending on the experimental
requirements. Placental explants were incubated in pre-
gassed medium under normoxic conditions (controls) (10%
O2/85% N2/5% CO2) or were subjected to hypoxia (0.5%
O2/94.5% N2/5% CO2) for 3 hours and subsequent reox-
ygenation at normoxia (10% O2/85% N2/5% CO2) for the1450following 20 hours (NZ 4) (H/R treatment). All the inserts
were transferred into pre-gassed medium after 1 hour of
incubation. At the end of the 24-hour culture period, some
placental explants for each condition were ﬂash frozen in
liquid nitrogen and stored at 80C until further processing
for mRNA or protein, and a few were ﬁxed in 4% para-
formaldehyde overnight for immunohistochemical analysis.
Western Blot Analysis
Frozen villous samples were homogenized in ice-cold lysis
buffer (1 mL of buffer per 100 mg of tissue) containing
20 mmol/L Tris, pH 7.4, 1 mmol/L EGTA, 0.01% Triton
X-100, 1 mmol/L sodium pyrophosphate, 1 mmol/L sodium
orthovanadate, 10 mmol/L b-glycerol phosphate, 50 mmol/L
sodium ﬂuoride, and a complete mini protease inhibitor
cocktail (Roche Diagnostics, East Sussex, UK). Tissue
homogenates were centrifuged at 15,000  g, 4C for 20
minutes to remove tissue debris and the clear supernatants.
Protein concentrations were determined on the supernatant
using a bicinchoninic acid protein assay kit (Sigma-Aldrich,
Poole, UK). Lysates were mixed with 3 SDS-PAGE
sample buffer, boiled for 5 minutes, and allowed to return
to room temperature. Equal amounts of protein (20 to 30 mg)
were separated by SDS-PAGE using 10% polyacrylamide
resolving gels and were transferred onto nitrocellulose
membrane (Invitrogen, Paisley, UK) and subjected to im-
munoblot analysis. Membranes were blocked for 1 hour at
25C in 5% milk diluted in Tris-buffered saline and 0.1%
Tween 20 and incubated with the following primary anti-
bodies overnight at 4C: anti-CSE (diluted 1:500; Abnova,
Novus Biologicals, Cambridge, UK) and anti-CBS (diluted
1:500; Sigma-Aldrich). After washing and incubating with
secondary antibodies, immunoreactive proteins were
visualized by the ECL Plus chemiluminescence system
(Amersham Biosciences, Buckinghamshire, UK) following
the manufacturer’s instructions. Protein bands were quan-
tiﬁed using ImageJ software version 1.46r (NIH, Bethesda,
MD). Protein loading was normalized against Ponceau S
staining. We used Ponceau S as a loading control because
it has been validated and found to be comparable with
b-actin staining.31 The values are expressed as percentages
of the control lysate (100%) for each experiment.ajp.amjpathol.org - The American Journal of Pathology
Hydrogen Sulﬁde and Human PlacentaRNA Isolation and Quantitative Real-Time RT-PCR
Analysis
Total RNA was isolated from human placentas using an
RNeasy micro kit (Qiagen, Hilden, Germany). The RNA was
quantiﬁed by spectrophotometry (Nanodrop Technologies,
Wilmington, DE). In brief, 20 mg of total RNA from each
sample was reverse transcribed using a master mix containing
SuperScript II Reverse Transcriptase (Invitrogen). The ABI
PRISM 7700 sequence detection system (ABI, Warrington,
UK) was used to perform real-time PCR according to the
manufacturer’s protocols. CT values for each transcript (ie,
CSE, CBS) were compared with those for 18S rRNA. RNU48
was used as an endogenous control for real-time PCR quanti-
ﬁcation of miR21. All the primers and probes were obtained
from Applied Biosystems Assays-on-Demand (ABI) and used
a 50 FAMreporter and a 30 nonﬂuorescentminor groovebinder.
Colorimetric Immunohistochemical Analysis
Paraformaldehyde-ﬁxed tissues embedded in parafﬁn wax
were sectioned at 7 mm. After dewaxing and blocking of
endogenous peroxidases by incubation with 3% H2O2 for
30 minutes, the sections were incubated with nonimmune
serum for 20 minutes. Primary antibodies [anti-CSE (diluted
1:300; Abnova) and anti-CBS (diluted 1:200; Sigma-
Aldrich)] were applied overnight at 4C, and binding was
detected using Vectastain Elite ABC kits (Vector Labora-
tories, Burlingame, CA) and SigmaFast diaminobenzidine
(Sigma-Aldrich) according to the manufacturers’ instruc-
tions. Sections were lightly counterstained with hematox-
ylin. When necessary, antigen retrieval was performed
before blocking using 1 mmol/L Trise0.1 mmol/L EDTA
buffer, pH 9.0, in a pressure cooker for 2 minutes. Negative
controls were performed by replacement of primary anti-
body with equal concentrations of nonimmune serum.
Placental Perfusion
Perfusion pressure and ﬂow (Transonic Systems Inc., Ithaca,
NY)weremeasured in eight healthy cesarean-delivered human
placentas. The placental perfusion protocol was modiﬁed from
that of Brownbill and Sibley.32 Brieﬂy, a single lobe from each
placenta was perfused with equilibrated (95%O2/5% CO2, pH
7.4) Earle’s bicarbonate buffer containing dextran 70 (mol. wt.
70 to 80 kDa) (31390; Sigma-Aldrich), 1% bovine serum
albumin, 0.402 mmol/L L-arginine, and 10 UI/mL of heparin
(Wockhardt UK Ltd., Wrexham, UK) by cannulating the
chorionic artery and vein of the lobe. The basal pressure was
settled at 30 to 40 mm Hg, with a constant ﬂow for 20
minutes. The ﬂow to achieve this perfusion pressure was
regulated between 5 and 8mL.min1 (depending on the lobule
size), with a peristaltic pump giving a ﬁxed pulsatility of 160
bpm. The experiments were performed at a constant ﬂow and
pulsatility (rate). Placentas that did not stabilize pressure after
20 minutes of a constant ﬂow and rate were thus rejected.The American Journal of Pathology - ajp.amjpathol.orgThe catheters implanted in the chorionic artery were connected
to sterile pressure transducers set at the placental chorionic plate
level (COBE; Argon Division, MaxximMedical, Athens, TX),
and these pressures were recorded continuously by a custom-
built data acquisition system (Maastricht-Programmable
AcQuisition system; Maastricht Instruments, Maastricht,
The Netherlands) at a 500-Hz sample rate. The Gilson Min-
ipuls 2 peristaltic pumps (Anachem, Luton, UK) used were
appropriately set for each placenta to maintain 30- to 40-mm
Hg arterial pressure (simulating the in vivo physiologic
umbilical arterial pressure). To ﬁx ﬂow without signiﬁcantly
altering the pulsatility, we used different inside diameters for
the tubing in the peristaltic pump.
After preconstriction with the thromboxane mimetic
U46619 (107 mol/L; Cayman Chemical, Ann Arbor, MI),
increasing doses of NaHS solution (1012 to 106 mol/L)
were infused. Glibenclamide (105 mol/L) was adminis-
tered to block KATP channels and L-NAME (10
5 mol/L) to
inhibit endogenous NO synthesis in a continuous manner
in the perfusate before preconstriction with U46619. The
placenta reached steady state constriction after 5 to 10
minutes of the U46619 infusion. After 3 minutes of steady
plateau, the increasing doses of NaHS were given. The
L-NAME and glibenclamide blockades were given in the
infusion (perfusate), and the NaHS was administered in 5-
mL boluses, replacing the perfusate infusion (therefore,
the concentration in the lumen is that infused during the 40
to 60 seconds that last the bolus, depending on the ﬂow
rate). Between boluses, a waiting period of 3 to 5 minutes
was introduced (with the perfusate) until reaching a plateau
in the vasodilator response.
Flow and pressure were continuously recorded by a 2R
ﬂow probe connected to a T106 monitor (Transonic Systems
Inc.) and the Maastricht-Programmable AcQuisition system.
The ﬂow was compared with the venous output, conﬁrming
the integrity of the vessel network at the beginning and end
of the experiment. Doses of U46619, glibenclamide, and
L-NAME were optimized in pilot experiments.
Statistical Analysis
Data are expressed asmeans SEM. Comparisons weremade
using a 2-tailed t-test or analysis of variance with a Student
Newman-Keuls post hoc test or Wilcoxon nonparametric test
where appropriate. Differences were considered to be signiﬁ-
cant at P  0.05.
Results
Localization and Expression of CBS and CSE in Healthy
and Pathologic Human Placentas
CBSwas localized only to the syncytiotrophoblast (Figure1A).
In contrast, CSE was immunolocalized principally to the
SMCs surrounding the large placental stem villus arteries
(Figure 1B). We investigated whether the potential for1451
Figure 1 Placental immunostaining. Localiza-
tion of CBS (A) and CSE (B) in human placentas
from healthy cesarean-delivered (CS), IUGR, PE-
AD, and PE-ND pregnancies and localization of
CSE in term human placental explants cultured at
different oxygen concentrations [ie, normoxia
(10% O2 for 20 hours) and H/R (0.5% O2/10% O2
for 20 hours)] (C). D: Negative control stained by
replacing primary antibody with nonimmune
serum. Brown color signiﬁes positive staining. CBS
localized in the syncytiotrophoblast, whereas CSE
was predominantly expressed by SMCs of large
placental arteries. Scale bars Z 100 mm.
Cindrova-Davies et alsynthesis of H2S was deﬁcient in placentas from pregnancies
complicated by PE and IUGR. Protein (Figure 2) and mRNA
(Figure 3) expression levels of CSE were signiﬁcantly
decreased in IUGR and PE-AD placentas compared with
healthy placentas delivered by cesarean birth. However, this
was not the case in PE-ND samples, which had unaltered
mRNA CSE expression (Figure 3) and even marginally
increased CSE protein expression (Figure 2C). Reduced
placental expression of CSE thus associated with increased
placental vascular resistance, as assessed by umbilical Doppler
velocimetry. There were no differences in protein (Figure 2) or
mRNA (Figure 3) levels of CBS among the four different
groups. The protein expression ofCBS andCSEwas examined
by Western blot analysis, and bands of approximately 43 kDa
corresponding to CSE and approximately 61 kDa corre-
sponding to CBS were recognized. Immunohistochemical
analysis results matched the protein ﬁndings (Figure 1, A and
B). We used a semiquantitative scale from 0 to 3 to analyze six
randomly selected areas per four slides per group at 40
magniﬁcation: 0Z no staining, 1Zweak intensity of staining,
2 Z moderate staining, and 3 Z strong staining. Randomly
selected slides showed that controls exhibited a staining score
of 2.6; PE-AD, 1.7; and PE-ND, 2.7.1452We used term cesarean-delivered healthy placentas as
controls for these experiments. Signiﬁcant differences in
means  SEM gestational ages among control (39  0.6
weeks), IUGR (32  3.5 weeks), PE-AD (28.5  1.3
weeks), and PE-ND (29.5  1.5 weeks) samples (Table 1)
reﬂect the inability to obtain cesarean-delivered healthy
preterm controls to match the gestational age of severe
IUGR and PE samples that were delivered prematurely for
clinical reasons. However, no differences in CBS mRNA
expression were reported between ﬁrst-trimester and term
human placentas.33 It is, thus, unlikely that the reduction in
CSE expression in pathologic pregnancies is due to differ-
ences in gestational age. Both proteins are present in early
placental samples and display the same localization as in
term samples (data not shown).
miR-21 as a Potential Regulator of CSE Expression
Because recent evidence suggests that SMC CSE expression
could be regulated by miR-21,25 we quantiﬁed miR-21
expression using quantitative real-time-PCR in PE and
IUGR placentas compared with controls and found signiﬁ-
cant up-regulation of miR-21 expression in IUGR andajp.amjpathol.org - The American Journal of Pathology
Figure 2 Protein expression proﬁles of placentas. Protein expression of CBS and CSE in IUGR (A) and PE-AD (B) or PE-ND (C) placentas compared with
cesarean-delivered (CS) controls. Lysates from CS control (n Z 6), IUGR (n Z 6), PE-AD (n Z 6), and PE-ND (n Z 7) placentas were immunoblotted with
antibodies against CSE and CBS. Ponceau S (Ponc) expression served to normalize gel loading. Normalized results (means  SEM) are plotted, expressing CS
controls as 100%. *P < 0.05 versus CS controls (one-way analysis of variance and Student Newman-Keuls test).
Hydrogen Sulﬁde and Human PlacentaPE-AD placentas. There was no change in miR-21 expres-
sion in PE-ND placentas (Figure 3). These results inversely
match the changes in CSE protein and mRNA expression
and are consistent with the hypothesis that miR-21 might
play a regulatory role in down-regulating CSE expression.
CBS and CSE Expression in Placental Explants
Challenged with H/R
We next explored the principal mechanism that would
regulate the changes in CSE expression by subjecting
placental explants to either normoxia or H/R for 20 hours
to mimic the conditions in severe IUGR and PE. We
measured explant protein and mRNA expression levels of
CSE and CBS and levels of miR-21 (Figure 4). In agree-
ment with the in vivo ﬁndings, compared with normoxicFigure 3 mRNA expression proﬁles of placentas. mRNA expression of
CBS and CSE and miR-21 in cesarean-delivered (CS) control, IUGR, PE-AD,
andr PE-ND placentas. RNA from CS control, IUGR, and PE placentas was
isolated, and relative levels of CBS and CSE mRNA or miR-21 were detected
using quantitative real-time RT-PCR. CBS and CSE mRNA levels were
normalized to the 18S RNA levels and miR-21 to the RNU48 levels. Results
are given as means  SEM. *P < 0.05 versus CS controls (one-way analysis
of variance and Student Newman-Keuls test).
The American Journal of Pathology - ajp.amjpathol.orgcontrols, H/R reduced the protein expression of CSE;
however, the expression levels of CBS remained signiﬁ-
cantly unchanged (Figure 4). The ﬁnding of reduced CSE
protein expression in H/R explants was conﬁrmed by
immunohistochemical analysis, which localized the protein
expression principally to SMCs (Figure 1C). In view of the
previous ﬁndings in the pathologic placentas, we also
examined miR-21 expression in placental explants and
found that H/R up-regulated miR-21 expression, providing
a mechanism for miR-21edriven reduction in CSE down-
regulation (Figure 4B).
H2S Effect on Perfused Human Placentas and the
Mechanism of Action
Given the evidence for reduced CSE expression and spec-
ulated reduction in H2S bioavailability associated with
adverse clinical outcomes in pregnancies complicated with
abnormal umbilical artery Doppler and, thus, increased
vasoconstriction, we decided to test whether H2S can act as
a vasodilator in the fetoplacental circulation. Perfusion of
cesarean-delivered human placentas obtained from healthy
term pregnancies with increasing doses of the H2S donor,
NaHS, induced concentration-dependent reductions in
perfusion pressure and vascular resistance after pre-
constriction with the thromboxane mimetic U46619 (107
mol/L). The effects of NaHS were signiﬁcantly attenuated in
the presence of the KATP channel blocker glibenclamide
(105 mol/L) in terms of perfusion pressure (Figure 5A) and
maximal relaxation (Figure 5, BeD). In addition, treatment
with 105 mol/L NO synthesis blocker L-NAME reduced
the vasodilator effect of NaHS, and this effect was inter-
mediate between the effects of treatment with glibenclamide
and treatment with NaHS alone (Figure 5, BeD).1453
Figure 4 Protein and mRNA expression proﬁles in placental explants.
Protein (A) and mRNA (B) expression of CBS and CSE and miR-21 expression
(B) in term placental explants cultured at different oxygen concentrations.
A: Lysates from term placental explants (nZ 4), which were cultured under
normoxia (10% O2) or H/R (1% to 10% O2) for 20 hours, were immuno-
blotted with antibodies against CSE and CBS. Ponceau S (Ponc) expression
served to normalize gel loading. Normalized results (means  SEM) are
plotted, expressing cesarean-delivered (CS) controls as 100%. *P < 0.05
versus CS controls (analysis of variance and the Protected Least Signiﬁcant
Difference test with P < 0.05). B: RNA was isolated and relative levels of
CBS and CSE mRNA or miR-21 were detected using quantitative real-time
RT-PCR. CBS and CSE mRNA levels (means  SEM) were normalized to the
18S RNA levels and miR-21 to the RNU48 levels. *P < 0.05 H/R versus
normoxic controls (Wilcoxon nonparametric test).
Cindrova-Davies et alDiscussion
These studies demonstrate that reduced placental CSE
expression at the mRNA and protein levels is associated
with abnormal umbilical artery Doppler waveforms in high-
risk pregnancies. These are novel observations that need to
be further conﬁrmed. They allude to the potential role of
decreased H2S availability in the pathogenesis of increased
umbilical arterial resistance in cases of severe preterm
IUGR. We suggest that these changes are epigenetically
regulated because the expression of miR-21, which has been
reported to play a role in CSE down-regulation,25 is elevated
in these abnormal placentas. We mimicked the changes in
CSE and miR-21 expression in normal placental explants
subjected to H/R, providing a mechanism to integrate these
ﬁndings with the known underlying pathology of the ute-
roplacental circulation.34 CSE protein and mRNA expres-
sion were unaffected in placentas from PE-ND pregnancies,1454implying that H2S acts as a local fetoplacental vasodilator
agent. This was conﬁrmed by administering increasing
doses of the H2S donor, NaHS, which decreased vascular
resistance in a dose-dependent manner. We found the effects
of NaHS to be signiﬁcantly attenuated in the presence of the
KATP channel blocker glibenclamide in terms of perfusion
pressure and maximal relaxation; however, the effect of
treatment with the NO synthesis blocker L-NAME was
intermediate between the effects of treatment with gliben-
clamide and treatment with NaHS alone. These observations
imply that the primary dilator actions of H2S in the human
placenta are mediated via KATP channels and that there is an
additional interaction between H2S and NO that functions to
modulate vascular tone. There are potential interactions
between NO and H2S for NO donor treatmenteenhanced
endogenous production of H2S from rat aortic tissues.
NO can increase CSE activity in vascular tissues via
cGMP-dependent protein kinases and by regulating CSE
expression.20
Patel et al22 conﬁrmed endogenous H2S production and
the presence of CSE and CBS in rat and human intrauterine
tissues. These authors additionally reported endogenous
H2S production in the human placenta but did not identify
the cellular source. Herein, we immunolocalized CSE to the
SMCs of large placental vessels and to the syncytio-
trophoblast; however, CBS expression was conﬁned to the
outer syncytiotrophoblast layer of placental villi. This
pattern matched reports of different tissue localizations of
the two enzymes in other systems. CSE is expressed in
vascular SMCs but not in the endothelium,17,20,35 whereas
CBS is predominantly found in the brain. CBS protein
localizes in most areas of the brain but is predominantly
expressed in the cell bodies and neuronal processes of
Purkinje cells and Ammon’s horn neurons,36,37 and it does
not play an important role in cardiovascular tissues.38
We investigated whether the potential for synthesis of
H2S was deﬁcient in placentas from pathologic pregnancies.
PE and IUGR are the most serious perinatal complications
of human pregnancy that adversely affect maternal and fetal
health. They are associated with deﬁcient uteroplacental
vascular conversion, leading to maternal placental malper-
fusion.26,27 In the more severe cases, there is evidence of
associated increased resistance in the umbilical circulation,
resulting in reduced, or even reversed, end-diastolic ﬂow.1
Therefore, it was of interest to determine the localization
of the two H2S-generating enzymes in these placentas. We
found that the protein and RNA expression levels of CSE
were signiﬁcantly decreased in IUGR placentas and in PE-
AD placentas, which also had a trajectory for IUGR,
compared with cesarean-delivered healthy placentas or PE-
ND placentas. These are striking results and suggest that
reduced H2S production could contribute to fetoplacental
vasoconstriction in these growth-restricted placentas. There
were no differences in CBS expression among the four
different groups. In the human placenta, the terminal villi
are the principal sites of gaseous exchange. The capillaryajp.amjpathol.org - The American Journal of Pathology
Figure 5 Perfusion pressure and vasodilator
response in human placentas. A: Perfusion pres-
sure (percentage of U46619 Michaelis constant
Km) during the experimental protocol for two
healthy human placentas. Top arrows show
preconstriction with the thromboxane mimetic
U46619. Bottom arrows show logarithmic scale of
NaHS concentration. Different line colors represent
different placentas. Set of curves: basal response
(untreated) (left panel); responses in the pres-
ence of the NO synthase blocker L-NAME (middle
panel); and responses in the presence of the KATP
blocker glibenclamide (right panel). B: Vasodi-
lator response to NaHS in human placentas. Values
are means  SEM for the concentration-response
curves (B), the area above the curve (C), and the
maximal relaxation (%Rmax) (D) to NaHS. Groups
are untreated placentas (C; n Z 6), placentas
treated with the NO synthase blocker L-NAME (LN;
n Z 6), and placentas treated with the KATP
blocker glibenclamide (Glib; n Z 6). *P < 0.05
versus the untreated group; yP < 0.05 versus the
L-NAME group (one-way analysis of variance and
Student Newman-Keuls test).
Hydrogen Sulﬁde and Human Placentanetwork within them is supplied by the umbilical arteries
that branch into a series of resistance arteries contained in
the distributing stem villi. As there is no nerve supply in the
placenta, vasomotor control of the resistance arteries is
performed by locally produced vasoactive molecules. The
syncytiotrophoblast expresses endothelial NO synthase,
heme oxygenase, and CBS and, as such, produces NO, CO,
and H2S locally. The half-life of these gaseous molecules is
seconds (NO) to minutes (CO and H2S). In addition, NO
and CO are produced by vascular endothelial cells, whereas
H2S is produced by vascular SMCs. These vasodilators are
likely to interact, mediate the vascular tone locally, and act
as signaling molecules.39
We then investigated a potential mechanism that controls
CSE suppression. Yang et al25 recently reported the in-
volvement of miR-21 in down-regulation of the SMC
expression of CSE. miRNAs are endogenous small single-
strand noncoding RNAs of approximately 22 nucleotides
that control gene expression by targeting the 30 untransla-
tional regions of mRNAs for degradation and/or translational
repression.40e42 miR-21, an oncogenic antiapoptotic miRNA
that can affect proliferation, migration, and invasion,43,44 has
been shown to be aberrantly overexpressed in some cardio-
vascular conditions, such as cardiac hypertrophy induced by
aortic banding, which could be reversed by miR-21 down-The American Journal of Pathology - ajp.amjpathol.orgregulation,45 or the heart tissue of patients with end-stage
heart failure.46 Angiotensin II can increase miR-21 expres-
sion in neonatal rat cardiomyocytes in vitro.47 These data
suggest that miR-21 could be a new pathologic factor and
potentially a therapeutic target in cardiovascular disorders,
including complicated pregnancies with increased vascular
resistance.
Most of the pathologic placentas were associated with
abnormal umbilical Doppler velocimetry. Altered vascular
reactivity in IUGR could be a consequence of reduced
generation of vasodilators, increased expression of constric-
tors, modiﬁed oxygen tension, and/or oxidative stress. These
ﬁndings suggest that reduced CSE expression and conse-
quent reduced H2S bioavailability contribute to the IUGR
pathology by increasing resistance in the umbilical circula-
tion, which manifests as reduced or even reversed end-
diastolic blood ﬂow. The study design did not allow us to
test this hypothesis directly. Such experiments would require
the administration of an enzyme substrate to placentas from
healthy and complicated pregnancies, the worthy subject of
a future investigation.
Note that in the perfusion protocol, the perfusion medium
was gassed with 95% O2. Recently, some researchers have
moved away from using 95% O2. However, it is yet to be
determined what is the best percentage of O2 to use for1455
Cindrova-Davies et ala perfusion preparation to compensate for the lack of hemo-
globin. Most perfusion setups are focused on placental transfer
and metabolism, and few protocols have been published to
assess vascular chorionic reactivity. We used this 95% O2
mixture based on our previous unpublished experiments and
those of others.48,49 Although there is evidence that some
vasoconstrictors may have better responses at low oxygen
levels in isolated arteries and veins,50,51 there is no consensus
as to different responses to oxygenation changes.
Holwerda et al23 also studied the expression of CBS and
CSE in early-onset PE samples and reported a reduction in
the mRNA expression of CBS and no changes in the protein
or RNA expression of CSE or in the protein expression of
CBS. The reasons for the differences in these ﬁndings are
unclear, but they could be a reﬂection of several factors,
including antibody speciﬁcity, timing of tissue collection,
and/or variation in the severity of the pathology. To rein-
force these ﬁndings in the pathologic placentas, we studied
changes in placental CBS and CSE expression in placental
explants subjected to H/R. This stimulus is recognized to
mimic the ischemia-reperfusion consequences of deﬁcient
conversion of maternal spiral arteries, the underlying causes
of the oxidative stress, which precipitates the symptoms of
IUGR and PE.26,27 We found that compared with normoxic
explants, the protein and mRNA expression of CSE was
signiﬁcantly reduced and the expression of miR-21 increased
by H/R, conﬁrming that ischemia-reperfusion could be the
mechanism that leads to up-regulation of miR-21 and
subsequent inhibition of placental CSE expression. We
found no signiﬁcant differences in the expression levels of
CBS in these explants, again matching the in vivo ﬁndings.
The mechanism of the vasodilator action of H2S has been
established to be primarily mediated by KATP channels, which
can be potentiated by NO. For example, an intravenous H2S
injection transiently decreased the arterial blood pressure of
rats,20 an effect that could be mimicked by a KATP channel
opener, pinacidil, and blocked by glibenclamide. H2S might
induce reduction of disulﬁde bonds of the KATP channel
protein.52 H2S also induced in vitro relaxation of the aorta and
the portal vein of rats,20,21 acting mainly through the opening
of KATP channels in vascular SMCs and partially through
a Kþ conductance in endothelial cells. Unlike NO and CO,
which mediate vasorelaxation largely by cGMP pathway
activation, the vasorelaxant effect of H2S is independent of the
cGMP pathway.20 In addition, NO synthesis and effects
depend largely on endothelial function integrity, whereas H2S
is an endothelium-independent vasodilator and exerts its direct
effect on SMCs. In fact, H2S is the only endogenous gaseous
KATP channel opener known in these cells, and, notably, the
CSE enzyme was immunolocalized largely to the SMCs
surrounding the stem villus arteries. The interactions between
NO and H2S are highlighted by experiments in which treat-
ment with a NO donor enhanced endogenous production of
H2S in rat aortic tissues.
20 NO can also increase CSE activity
in vascular tissues via cGMP-dependent protein kinases and
by regulating CSE expression.20 In addition, the vascular1456effect of H2S can be potentiated by NO.
20,21 We, therefore,
tested the effect of the KATP channel blocker glibenclamide
and the NO synthesis blocker L-NAME when applied with
NaHS in perfused human placentas. We found the effects of
NaHS to be signiﬁcantly attenuated in the presence of gli-
benclamide in terms of perfusion pressure and maximal
relaxation, whereas the effect of treatment with L-NAME was
intermediate between the effects of treatment with glibencla-
mide and treatment with NaHS alone. This, again, implies that
the primary vasodilator mechanism of H2S in the human
placenta is mediated via KATP channels and an additional
interaction between H2S and NO.
Collectively, the three experiments show that H2S is
a potent vasodilator of the human placenta and that its
synthesis is impaired under conditions of hypoxia and
reoxygenation and in pathologic PE and IUGR pregnancies
with abnormal umbilical artery Doppler waveforms. These
data suggest an epigenetic mechanism whereby impaired
placental H2S generation occurs in complicated pregnancy.
Furthermore, the bioavailability of H2S might be a novel
mechanistic target for therapeutic interventions to improve
placental perfusion and protect fetal growth and develop-
ment in complicated pregnancies.Acknowledgments
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